Company Filing History:
Years Active: 2024
Title: Jacquelyn Sousa: Innovator in SARS-CoV-2 Modulation
Introduction
Jacquelyn Sousa is a prominent inventor based in Boston, MA, known for her significant contributions to the field of biotechnology. She has made strides in developing innovative solutions to combat viral infections, particularly those caused by SARS-CoV-2.
Latest Patents
Jacquelyn Sousa holds a patent for "Oligonucleotides for SARS-CoV-2 modulation." This patent discloses novel SARS-CoV-2 targeting sequences and provides innovative oligonucleotides aimed at treating SARS-CoV-2 infections. Her work represents a crucial advancement in the ongoing fight against the COVID-19 pandemic.
Career Highlights
Jacquelyn is affiliated with the University of Massachusetts, where she continues her research and development efforts. Her academic background and expertise in molecular biology have positioned her as a key figure in her field.
Collaborations
Jacquelyn has collaborated with notable colleagues, including Anastasia Khvorova and Jonathan Watts, who share her commitment to advancing scientific knowledge and developing effective treatments.
Conclusion
Jacquelyn Sousa's innovative work in the development of SARS-CoV-2 targeting oligonucleotides highlights her dedication to addressing critical health challenges. Her contributions are paving the way for future advancements in viral infection treatment.